Coverage Wire
BLKBUY$1216.61PANWSELL$322.66ZHOLD$28.80HDBUY$350.44NVDAHOLD$165.16MSTRSELL$114.00DISBUY$119.65PLTRSELL$173.70CSCOHOLD$101.85RTXHOLD$199.49AMATBUY$372.53JPMBUY$342.07CRWVSELL$47.94CVXBUY$209.59NEMHOLD$125.16TSLASELL$378.05WFCBUY$85.08EQIXSELL$1012.71BLKBUY$1216.61PANWSELL$322.66ZHOLD$28.80HDBUY$350.44NVDAHOLD$165.16MSTRSELL$114.00DISBUY$119.65PLTRSELL$173.70CSCOHOLD$101.85RTXHOLD$199.49AMATBUY$372.53JPMBUY$342.07CRWVSELL$47.94CVXBUY$209.59NEMHOLD$125.16TSLASELL$378.05WFCBUY$85.08EQIXSELL$1012.71
★
My Book
3
Terminal
Ctrl+K
Industry: Semiconductors • Horizon: 12-18 Months • Gravity: OVERWEIGHT
$204.57
-$3.54 (-1.70%) Today
Market Cap
$4.94T
Trailing P/E
26.1x
Forward P/E
13.0x
FCF Yield
0.84%
Dividend Yield
0.48%
Beta
2.25
Gross Margin
74.67%
Operating Margin
66.24%
📈 TradingView Real-Time Chart & Technical Action
🛡️ Put Wall Floor
$180.00
10.0% downside buffer
🎯 Desk Buy Zone
$188.00 – $196.00
Tactical accumulation band
🧲 Options Max Pain
$195.00
OPEX dealer pin strike
⚡ Call Wall Ceiling
$220.00
Overhead gamma supply
🚨 Thesis Stop-Loss
$176.00
Hard risk invalidation
🕸️ Institutional Trader Pentagon (NVDA)
74 / 100 COMPOSITE
🎛️ Interactive “What-If” Valuation & 10-Yr Yield Sensitivity Sandbox (NVDA)
10-Yr US Treasury Yield
4.86%
3.00% (Dovish Pivot)
6.50% (Rate Shock)
5-Yr EPS / FCF CAGR
18.0%
0% (Stagnation)
35% (Hyper-Growth)
Target Exit P/E Multiple
25.0x
8.0x (Value Compression)
50.0x (Premium Multiple)
Implied Fair Value & Margin of Safety
$228.40
+11.6% Implied Upside vs Spot
⚖️ CRO Position-Sizing & Asymmetric Risk/Reward Engine (NVDA)
Account Presets:
Portfolio Capital ($)
Max Stop-Loss Risk %
1.00% ($1,000)
Optimal Risk-Sized Position
$4,910 Allocation (4.9% of Book)
CRO Stop-Loss & Tier Cap
Hard Stop: $176.00 (-14.0%)
✓ Enforced 5.0% Core Position Cap
Asymmetric Reward / Risk
1.85 : 1
+$1,280 Upside vs -$685 Risk
📊 Live Financial Statements, Valuation Multiples & Technical Oscillators (NVDA)
Real-Time Balance Sheet, Income Statement, Cash Flow & Multi-Timeframe Gauges
🎯 Multi-Timeframe Technical Oscillator & Moving Average Rating
🏢 Corporate Profile, Industry Classification & Executive Leadership
📑 Standardized Fundamental Ratios, Valuation Multiples, Margins & Financial Statements
🛡️ AllWallSt Institutional Diagnostic Tear-Sheet & Risk Bounds
Sign-off: Alexander Sterling (Valuation) & Marcus Wolfe (Forensic Desk)
Valuation Multiple & FCF Yield
26.1x P/E
FCF Yield: 0.84% • Negative spread vs 4.95% US 10-Yr Benchmark.
Forensic Screener (Marcus Wolfe)
LOW ANOMALY RISK
Pristine cash flow conversion; accruals within healthy historical range.
Credit & Solvency Profile
Net Cash Surplus
Fortress liquidity buffer; negative net debt / zero near-term refinancing strain.
Options Market Structure (30-Day)
$188 – $224 Channel
Options Max Pain strike pinned near institutional gamma center.
Dealer Gamma Pinning & Max Pain Alignment
Institutional Expected Channel • CBOE / OPRA Flow
🎯 Max Pain: $195.00
▼ Floor $180 Support
Spot $195.00
Ceiling $210 Resistance ▲
Market Structure: Dealer positioning bounded between put support and call resistance.
Expected Channel: Monitored
Risk Governance:
Tier 3: Aggressive Growth • 1.5% – 2.5% Tactical Allocation
Target Entry Zone:
$192.30 – $200.48 (Options Support Pinning)
Thesis Invalidation:
Sustained weekly close below $180.00 or gross margin compression.
Benchmark Gravity:
OVERWEIGHT • Outsized index concentration in SPY/QQQ benchmarks.
Channel Gauge Guide:
🎯 Pin Badge marks Max Pain magnet. Cyan Band shows dealer 30D expected range. White Cursor tracks live Spot price, framed between Emerald Floor and Rose Ceiling.
🔍 Marcus Wolfe Forensic Accounting Reality Matrix (NVDA)
LOW ANOMALY RISK
Primary SEC EDGAR Cash Flow & Accrual Verification
Sloan Accrual Ratio
8.39%
Accruals vs Total Assets. Low-risk threshold is ≤ 10%.
Cash Flow Conversion
0.86x
Operating Cash Flow / GAAP Net Income. Pristine conversion ≥ 0.85x.
Working Capital Divergence
Normal Spread
Receivables & inventory expansion in balance with revenue growth.
Balance Sheet Liquidity
-$23.61B Net Cash
Cash reserves exceed total funded borrowings. Zero solvency wall strain.
Marcus Wolfe Desk Finding:
Pristine cash flow conversion; accruals within healthy historical range.
🏛️ AllWallSt Research Call Timeline & Track Record (NVDA)
AUDITED ENTRIES
Historical Research Verdicts, Publication Prices & Open Alpha
🗓️ Multi-Horizon Catalyst & Statutory SEC Filing Rail (NVDA)
Official Filings, Earnings Catalysts & Monthly OPEX
Next Earnings Release
2026-11-17
Consensus EPS: $2.47 • Rev: $109.0B
Monthly Options OPEX
2026-11-20
Monthly dealer gamma unwinding & pin window
Macro Rates Spread
4.95% Benchmark
US 10-Yr Treasury Hurdle Rate
Statutory Reporting Status
Form 10-K / 10-Q Active
SEC EDGAR Issuer Verified
📚 AllWallSt Research Coverage & Editorial Dossier
1 Published Note(s)
Official Regulatory Filings:
📄 Form 10-K (Annual Report)
📊 Form 10-Q (Quarterly Report)
🕵️ Form 4 (Insider Transactions)
🏛️ SEC EDGAR Browse Portal